1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with yohimbine in 8 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 5,893 | 253 | 532 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | yohimbine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
| D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Baldenkov, GN; Grigorian, GIu; Mazaev, AV; Negresku, EV; Tkachuk, VA | 1 |
| Calixto, JB; Trebien, HA | 1 |
| Fouque, F; Parini, A; Schattner, M; Touqui, L; Vargaftig, BB | 1 |
| Fouque, F; Vargaftig, BB | 1 |
| Goldenberg, MM; Meurer, RD | 1 |
| Flores, NA; Goulielmos, NV; Seghatchian, MJ; Sheridan, DJ | 1 |
| Rasheed, H; Saeed, SA | 1 |
8 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and yohimbine
| Article | Year |
|---|---|
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
[Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+].
Topics: Blood Platelets; Calcium; Cyclic AMP; Depression, Chemical; Epinephrine; Humans; Norepinephrine; Phentolamine; Platelet Activating Factor; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Serotonin; Stimulation, Chemical; Vasopressins; Yohimbine | 1989 |
Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom.
Topics: Animals; Captopril; Crotalid Venoms; Dexamethasone; Edema; Hot Temperature; Indomethacin; Male; Masoprocol; Platelet Activating Factor; Prazosin; Quinacrine; Rats; Rats, Inbred Strains; Reference Values; Yohimbine | 1989 |
Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.
Topics: 5-Hydroxytryptophan; Binding, Competitive; Diterpenes; Drug Synergism; Epinephrine; Ginkgolides; Glyceryl Ethers; Humans; In Vitro Techniques; Lactones; Morpholines; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Thiazoles; Yohimbine | 1989 |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
Topics: Adenosine Triphosphate; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Serotonin; Thrombin; Yohimbine | 1984 |
A pharmacologic analysis of the action of platelet-activating factor in the induction of hindpaw edema in the rat.
Topics: Animals; Carrageenan; Dexamethasone; Dose-Response Relationship, Drug; Edema; Hindlimb; Indomethacin; Male; Muscles; Phentolamine; Platelet Activating Factor; Rats; Rats, Inbred Strains; Regional Blood Flow; Theophylline; Verapamil; Yohimbine | 1984 |
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects.
Topics: Animals; Arrhythmias, Cardiac; Aspirin; Biphenyl Compounds; Blood Platelets; Colforsin; Diterpenes; Electrophysiology; Ginkgolides; Guinea Pigs; Heart; Heptanoic Acids; Lactones; Male; Myocardial Ischemia; Oxidopamine; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Receptors, Thromboxane; Yohimbine | 1994 |
Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Azepines; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Drug Synergism; Epinephrine; Flurbiprofen; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Signal Transduction; Triazoles; Verapamil; Yohimbine | 2003 |